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Background: Postoperative ileus is common after surgery. One non-pharmacological intervention that has shown
promising results in reducing the duration of postoperative ileus is chewing gum after surgery. However, this has
not been investigated in upper gastrointestinal surgery such as pancreatic surgery. Hence the aim of this study was
to investigate the effects of chewing gum treatment on patients undergoing pancreaticoduodenectomy ad modum
whipple due to pancreatic or periampullary cancer.
Methods: This study was conducted as a phase III trial that was terminated early. Patients diagnosed with pancreatic
tumours scheduled for pancreaticoduodenectomy ad modum whipple were included. The treatment group received
chewing gum postoperatively and standard care. Controls received glucose solution and standard care. Chewing gum
and glucose were used four times a day during the whole hospital stay. Time to first flatus and stool was defined as the
primary outcome. The secondary outcome was start with clear liquids, start with liquid diet and length of hospital stay.
Results: No statistically significant differences could be observed between the chewing gum intervention group and
the control group. However, a numerical difference in mean time was observed in first flatus, first stool, start of clear
fluids, and start of liquid diet and length of hospital stay in favour of the intervention group.
Conclusions: Although this study did not find statistically significant differences favouring the use of chewing gum for
postoperative ileus, a positive trend was observed of a reduction of the impact of postoperative ileus among patients
after pancreatic surgery. It also contributes valuable methodological experience that is important for future studies of
chewing gum interventions during recovery after pancreatic surgery.
Trial registration: ClinicalTrials.gov identifier: NCT02319512, publication date 2014-12-17.Background
Postoperative ileus (POI) is a common phenomenon
after abdominal surgery. POI is the interval between sur-
gery and passage of flatus/stool and tolerance of oral diet
and prolonged POI is defined as “two or more of
nausea/vomiting, inability to tolerate oral diet over 24 h,
absence of flatus over 24 h, distention and radiologic
confirmation on or after day 4 postoperatively without
prior resolution” [1]. The main reason is considered to in-
volve several factors such as: blocked extra cerebral
signaling and the sympathic nervous system, inflammatory
response (both local and systemic), and endocronological* Correspondence: thomas.k.andersson@vgregion.se
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unless otherwise stated.and hormonal effects [2]. Common symptoms of POI are
vomiting, nausea and abdominal pain. Due to the high
incidence of POI, it is considered a normal postopera-
tive reaction [3]. However, prolonged POI results in an
extended hospital stay and greater symptom burden for
the patient [4].
Several strategies and interventions have been tested
to prevent or reduce POI, both pharmacological and
non-pharmacological. One of these strategies is gum
chewing. Beneficial results have been shown in previous
studies after urological, colorectal, gynecological and
liver surgery [3,5]. These studies describe significantly
reduced time to the first postoperative bowel movement
[6-10], first flatus [6-11] and stool and shorter hospital
stay after using chewing gum. Two meta-analysestral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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surgery. A possible mechanism for these results may be
sham-feeding as a gastrointestinal response to neural
and endocrine influence equivalent to that of eating but
without the passage of food or fluid to the stomach.
Even though several studies have shown beneficial ef-
fects on recovery after different types of surgery, no
study has yet investigated the effect of chewing gum
treatment on recovery after major upper gastric surgery.
Pancreaticoduodenectomy (PD) is considered a major
surgical intervention with a high risk of prolonged POI
and delayed gastric emptying (DGE). For this reason, the
aim of this pilot study was to investigate the effects of
chewing gum treatment on patients undergoing pancrea-
ticoduodenectomy ad modum whipple due to pancreatic
or periampullary cancer.
Methods
This study was conducted as a phase III randomized,
controlled, trial at a university hospital in Sweden. Pa-
tients diagnosed with pancreatic or periamullary cancer
and scheduled to undergo pancreaticoduodencectomy
ad modum Whipple with a panceraticogastrostomy and
roux-en-y loop were included. Inclusion criteria were:
understand and speak Swedish, no diagnosed neuro-
logical injuries or diseases affecting the ability to swal-
low or gastric function, no ongoing treatment for
mental disease, no ongoing abuse of alcohol or other
drugs, no previously known allergies to the contents of
chewing gum. Primary outcomes were time to flatus/
stool and secondary outcomes were length of hospital
stay and start of clear liquids and fluid diet. Primary
and secondary outcomes were assessed though patient
records.
Procedure
Participants were included on the day of admission,
which was the day prior to surgery. Randomization to
the two groups (1:1) was done when patients returned
from the intensive care unit (ICU) to the ward. This
procedure was chosen in order to avoid perioperative
drop-outs due to inoperable tumors. A personnel from
an independent institution not involved in the study ad-
ministered pre-coded numbered, identical opaque enve-
lopes to assign to the groups. A computer generated
random table was used. The treatment group received
chewing gum and standard care. Controls received
standard care and sips of glucose, in total 3.6 g/day in a
12-ml mixture per day, the same amount of glucose per
day as the treatment group received via the chewing
gum. The chewing gum used was Chiza™, a natural or-
ganic gum whose main ingredients are latex, glucose
and natural flavors (lime or spearmint). Patients started
to chew after they returned from the ICU the day aftersurgery. Chewing gum was administered every fourth
hour (08.00-12.00, 12.00-16.00 and 16.00-20.00). During
each four-hour period, patients chewed two pieces of
gum for 30 minutes. Chewing gum was used during the
whole hospital stay. The time to the first postoperative
flatulence and defecation was recorded, in addition to
standard clinical data, by the first and the second authors.
Patients were monitored postoperatively at the ICU
for 24 hours before returning to the surgical ward. All
patients received a nasogastric tube perioperatively with
cautious suction, which was kept for seven days. All pa-
tients received continuous thoracic epidural infusion of
Bupivacain 1 mg/ml, Fentanyl 2 mg/ml and Adrenaline
2 mg/ml as an analgesic combined with intravenous
paracetamol four times a day; all patients received a pro-
ton pump inhibitor (PPI) during the entire hospital stay
and somastostatin for seven days postoperatively. When
the nasogastric tube was removed, patients were allowed
to start drinking a limited amount of clear liquids and
later liquid foods (e.g. soups) and easily digested foods
(e.g. fish). During fasting, patients received parenteral
nutrition of glucose and Smofkabiven™ based on individ-
ual needs. Blood glucose levels were tested every fourth
to sixth hour during the first postoperative week. When
fluids could be tolerated, the epidural analgesia was con-
verted to orally administered analgesia (Oxycodone and
Paracetamol) until discharge based on the individual
needs of the patient.
A standardized care plan focusing on rehabilitation,
patient education, psychosocial needs and monitoring
signs and symptoms was used in the postoperative nurs-
ing care to ensure equal and evidence based care.Statistics
Statistical power was calculated on the basis of results of
the study by Add-El-Maeboud et al. [6] in which the
mean value of time to the first flatulence was 17.9 h in
the treatment group and 24.4 h in the control group.
With a power of 80% and a level of significance of 0.05,
18 patients were needed in each group. As the variables
were not normally distributed, comparisons between the
groups were analyzed with non-parametric tests, the
Mann Whitney U test and Chi 2 test. The statistically
significant p value was set at <0.05.
Due to a radical change in postoperative care as well
as surgical technique, adopting the ERAS protocol for
pancreaticoduodenectomy [14], the study was termi-
nated in advance as this change in care procedures dif-
fered extensively from the previous strategies, e.g.
removal of the nasogastric tube much earlier in the
postoperative phase and not using parenteral nutrition
support as patients were allowed to start oral intake
much earlier.








Gender (Male/Female) 5/2 4/6 .201
Age, years 65.9 (8.7) 63.2 (9.2) .559
Duration of surgery, min 419.4 (96.1) 443.4 (97.4) .0881
Peroperative blood loss, ml 971 (971.4) 1720 (1650.2) .248
Number of participants or mean (±SD).
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Of 65 eligible patients, 51 fulfilled the inclusion criteria
and were included in the study. Of the 65 eligible, 14 de-
clined to participate for various reasons, e.g. not using
chewing gum in their everyday life or difficulties coping
with the postoperative situation in general and finding
participation in a clinical study too much to deal with. A
further 23 dropped out because of non resectable or
additional surgery because of postoperative bleeding.
The remaining 28 patients were randomized to the treat-
ment group or the control group by opaque, sealed en-
velopes prepared by one person at the department who
was independent of the study (Figure 1). Demographic
data are presented in Table 1.
Of the total of 28 patients, 14 were randomized to the
intervention group and 14 to the control group. Seven
patients in the intervention group chose to discontinue
participation in the study versus four in the control
group (Figure 1). The majority of those discontinued
participation because of postoperative symptoms such as
pain, nausea or fatigue.
Of the remaining patients, there was a numerical dif-
ference in mean time to first flatus, first defecation, start
of clear fluids, start of liquid diet and length of hospitalAssessed for e
Analysed  (n=7) 
Lost to follow-up (n=7) 
No reason given (n=2) 
Disliked chewing gum (n=1) 
Severe postoperative pain (n=2) 
Nausea (n=1) 
Postoperative confusion (=1) 






Figure 1 Consort flowchart.stay in favour of the intervention group, although not
strong enough to be statistically significant (Table 2).
No side effects of chewing were recorded.
Discussion
This is the first study of postoperative chewing gum to
show a reduction of POI in major upper gastric surgery.
Previous research has focused primarily on colon sur-
gery with beneficial results on the duration of POI. Con-
ducting a randomized controlled trial (RCT) with
chewing gum in this patient group was associated with
several difficulties, as demonstrated in the consort flow
diagram (Figure 1). Fourteen potential participants de-
clined participation. Reasons for being non participantsligibility (n=65) 
Excluded  (n=37) 
♦ Not meeting inclusion criteria (n= 14) 
♦ Declined to participate (n=19) 
♦ Other reasons (n= 4) 
Lost to follow-up (give reasons) (n=4) 
No reason given (n=2) 
Disliked sugar solution (n=1) 
Postoperative confusion (n=1) 
Allocated to controls (n=14) 




zed (n=28 ) 
Table 2 Postoperative findings in the intervention group and the control group in mean (±SD)
Intervention Control Calculated difference (p)
Time to first flatus (SD) (days) 3.7 (1.4) 5.6 (4.4) .340
Time to first defecation (SD) (days) 7.6 (2.7) 9.1 (6.2) .882
Start of clear fluids (SD) (days) 5.1 (2.7) 7.7 (3.5) .068
Start of liquid diet (SD) (days) 6.4 (2.7) 9.2 (3.6) .116
Length of hospital stay (SD) (days) 18.0 (4.9) 21.8 (6.5) .286
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willing to participate were excluded because of advanced
disease or a need of more extensive surgery, e.g. a total
pancreatectomy, or were found to have advanced
tumour growth, resulting in focusing on bypassing the
tumour rather than removing it. Despite comprehensive
preoperative screening, there is a risk of metastasis or
vessel overgrowth not being detected by a CT scan, and
some patients may therefore “slip” through the screening
process only to be found to have an advanced disease
that is detected perioperatively.
In this study, the mean time to first flatus and
defecation was shorter in the intervention group, al-
though the difference was not significant. This was also
seen in the time to start intake of clear fluids and a li-
quid diet. While the hospital stay has been observed to
be shorter, this study did not demonstrate any significant
differences between the two groups. This may be related
to the small number of participants and to the type of
surgery and the impact on the patient’s ability to cope
physically and mentally with its consequences for every-
day life, not only to POI. Length of hospital stay was
used as one outcome variable. However, in this type of
surgery, there is a major risk of postoperative complica-
tions that may increase the length of the hospital stay.
A power analysis based on the results of the current
study with 80% power and a significance level of 0.05 re-
veals that 37 patients per group is sufficient to show a
significant change between groups concerning length of
hospital stay, 46 for time to first flatus, 53 for start of
clear fluids and liquid food and 160 patients per group
for time to first defecation. Based on the results of this re-
verse power analysis, this study ought to be considered a
preliminary report, and larger prospective trials are needed.
Patients randomized to the intervention group were
affected by symptoms related to surgery such as pain,
nausea or fatigue affecting their ability to tolerate the
intervention. The use of a nasogastric tube with active
suction for seven days was also demanding for the pa-
tients, further reducing their ability to cope. We also
noted the importance of choosing the optimal chewing
gum, considering texture, and of offering different fla-
vours. Here, we used a biodynamic manufactured chew-
ing gum containing glucose and not a sugar free
alternative. This chewing gum had a somewhat differenttexture, and this might not appeal to everyone’s taste,
thus resulting in drop-outs from the study. In the future
it is important to focus on symptom management and to
make the intervention as least intrusive as possible.
While all the patients were very positive and interested
in participating in our study, some were not able to con-
tinue participation because of their postoperative symp-
toms such as nausea, pain and fatigue.
Conclusions
Even though this study does not demonstrate significant
differences between the groups, it does indicate a posi-
tive trend of reducing the POI impact among patients
after pancreatic surgery. It also contributes valuable ex-
perience for further studies on chewing gum interven-
tions during recovery after pancreatic surgery.
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